Oral Cancer: Page 102

Head/neck cancer drug shows promise in clinical trials
By DrBicuspid.com staff writers
CEL-SCI has begun a phase III clinical trial for Multikine, its flagship immunotherapy drug for head and neck cancer. The goal is to establish Multikine as a first-line standard of care therapy in treating newly diagnosed head and neck cancer patients.
January 5, 2011
Estrogen may help precancerous cells spread in oral cavity
By DrBicuspid.com staff writers
Estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity, according to a new study in Cancer Prevention Research.
January 3, 2011
Head and neck cancer treatments often don't meet guidelines
By Reuters Health
NEW YORK (Reuters Health) - Care for U.S. patients with head and neck cancers deviates significantly from national guidelines, if the findings of a new study hold true.
January 2, 2011
2010 01 21 15 43 33 498 Salivary Glands 70
Cigna dental program expands coverage, benefits
By DrBicuspid.com staff writers
Cigna Oral Health Integration Program now includes coverage for more conditions, including stroke, chronic kidney disease, head and neck cancer radiation, and organ transplants, the company announced.
January 2, 2011
Tumor location influences oral cancer recurrence
By DrBicuspid.com staff writers
Patients who have a recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or if it appears in the lymph nodes six months or longer after initial treatment, according to a study in Archives of Otolaryngology -- Head & Neck Surgery.
December 21, 2010
U.K. scientists find how HPV triggers oral cancer
By DrBicuspid.com staff writers
University of Manchester scientists have discovered for the first time an important new way in which the human papillomavirus (HPV) triggers cancer in what could lead to new treatments for cervical and oral cancer British Journal of Cancer.
December 13, 2010
Autofluorescence decline may indicate oral cancer
By DrBicuspid.com staff writers
Loss of tissue autofluorescence could be an early indicator of the presence of oral cancer, according to a study in the Journal of Craniofacial Surgery.
December 12, 2010
Zometa aids patients with head and neck cancer
By DrBicuspid.com staff writers
The bisphosphonate Zometa appears to reduce bone loss and decrease tumor size in patients with head and neck cancer, according to a study in Cancer Research.
December 12, 2010
2010 01 21 15 43 33 498 Salivary Glands 70
Smokeless tobacco firm settles oral cancer suit for $5M
By Donna Domino
U.S. Smokeless Tobacco has agreed to pay $5 million to the family of a North Carolina man who died after chewing tobacco for 27 years. Experts say this is the first wrongful death settlement involving smokeless tobacco.
December 6, 2010
2010 12 07 15 33 53 173 Tobacco Cans 70
DentLight launches oral cancer exam device
By DrBicuspid.com staff writers
DentLight has launched the DOE, a rechargeable battery-powered cordless dental oral health examination system, the company announced.
December 5, 2010
Oral cancer screenings questioned; dental students help the homeless
By Kathy Kincade
December 5, 2010
Cochrane review questions routine oral cancer screening
By Rosemary Frei, MSc
The scientific literature does not conclusively prove that routine visual screening for oral cancer increases detection and prevention, according to a new Cochrane review. Even so, the authors advise assessing high-risk individuals, and experts say it is still warranted.
December 1, 2010
2010 12 02 00 13 58 619 Cancer Cell 70
Previous Page
Page 102 of 117
Next Page